We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.

Cardiovascular

Menopause and blood clots (VTE)

Baseline VTE risk plus formulation determines individual risk. Transdermal is the safer default.

Key points

  • Transdermal safer
  • Screen personal/family Hx
  • Hematology if unclear

Frequently asked questions

Family history of clots?

Consider factor V Leiden testing; use transdermal.

Any HRT after DVT?

Case-by-case with hematology.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service

Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.

Ask Dot